PubMed

Monitoring warfarin therapy in patients with lupus anticoagulants.

Moll S, Ortel TL.

Ann Intern Med. 1997 Aug 1;127(3):177-85.PMID: 9245222 [PubMed - indexed for MEDLINE]Related articlesFree article

Unreliability of international normalized ratio for monitoring warfarin therapy in patients with lupus anticoagulant.

Rosborough TK, Shepherd MF.

Pharmacotherapy. 2004 Jul;24(7):838-42.PMID: 15303447 [PubMed - indexed for MEDLINE]Related articles

The international normalized ratio (INR) for monitoring warfarin therapy: reliability and relation to other monitoring methods.

Le DT, Weibert RT, Sevilla BK, Donnelly KJ, Rapaport SI.

Ann Intern Med. 1994 Apr 1;120(7):552-8.PMID: 8116992 [PubMed - indexed for MEDLINE]Related articlesFree article

Evaluation of the phospholipid-rich dilute Russell's viper venom assay to monitor oral anticoagulation in patients with lupus anticoagulant.

Thom J, Ivey L, Gilmore G, Eikelboom JW.

Blood Coagul Fibrinolysis. 2004 Jun;15(4):353-7.PMID: 15166923 [PubMed - indexed for MEDLINE]Related articles

Monitoring therapy with vitamin K antagonists in patients with lupus anticoagulant: effect on different tests for INR determination.

Bijsterveld NR, Middeldorp S, Berends F, Büller HR.

J Thromb Thrombolysis. 2000 Apr;9(3):263-9.PMID: 10728026 [PubMed - indexed for MEDLINE]Related articles

Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.

Clark NP, Witt DM, Delate T, Trapp M, Garcia D, Ageno W, Hylek EM, Crowther MA; Warfarin-Associated Research Projects and Other Endeavors Consortium.

Pharmacotherapy. 2008 Aug;28(8):960-7.PMID: 18657012 [PubMed - indexed for MEDLINE]Related articles

Monitoring of oral anticoagulant therapy in lupus anticoagulant positive patients with the anti-phospholipid syndrome.

Lawrie AS, Purdy G, Mackie IJ, Machin SJ.

Br J Haematol. 1997 Sep;98(4):887-92.PMID: 9326184 [PubMed - indexed for MEDLINE]Related articles

Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.

Della Valle P, Crippa L, Garlando AM, Pattarini E, Safa O, Viganò D'Angelo S, D'Angelo A.

Haematologica. 1999 Dec;84(12):1065-74.PMID: 10586206 [PubMed - indexed for MEDLINE]Related articlesFree article

Low frequency of elevated prothrombin times in patients with lupus anticoagulants when using a recombinant thromboplastin reagent: implications for dosing and monitoring of oral anticoagulant therapy.

Moore GW, Rangarajan S, Holland LJ, Henley A, Savidge GF.

Br J Biomed Sci. 2005;62(1):15-8; quiz 47.PMID: 15816206 [PubMed - indexed for MEDLINE]Related articles

Falsely elevated INRs in warfarin-treated patients with the lupus anticoagulant.

Sanfelippo MJ, Sennet J, McMahon EJ.

WMJ. 2000 Jun;99(3):62-4, 43.PMID: 10927985 [PubMed - indexed for MEDLINE]Related articles

Monitoring oral anticoagulant treatment with the TAS near-patient test system: comparison with conventional thromboplastins.

Kitchen S, Preston FE.

J Clin Pathol. 1997 Nov;50(11):951-6.PMID: 9462248 [PubMed - indexed for MEDLINE]Related articlesFree article

Therapeutic monitoring of warfarin: the appropriate response marker.

Costa IM, Soares PJ, Afonso M, Ratado P, Lanaot JM, Falcão AC.

J Pharm Pharmacol. 2000 Nov;52(11):1405-10.PMID: 11186249 [PubMed - indexed for MEDLINE]Related articles

Performance of prothrombin-proconvertin time as a monitoring test of oral anticoagulation therapy.

Haraldsson HM, Onundarson PT, Einarsdóttir KA, Guõmundsdóttir BR, Pétursson MK, Pálsson K, Kristinsson A.

Am J Clin Pathol. 1997 Jun;107(6):672-80.PMID: 9169664 [PubMed - indexed for MEDLINE]Related articles

Monitoring "mini-intensity" anticoagulation with warfarin: comparison of the prothrombin time using a sensitive thromboplastin with prothrombin fragment F1+2 levels.

Millenson MM, Bauer KA, Kistler JP, Barzegar S, Tulin L, Rosenberg RD.

Blood. 1992 Apr 15;79(8):2034-8.PMID: 1562730 [PubMed - indexed for MEDLINE]Related articlesFree article

Search for predictors of nontherapeutic INR results with warfarin therapy.

McGriff-Lee NJ, Csako G, Chen JT, Dang DK, Rosenfeld KG, Cannon RO, Macklin LR, Wesley RA; Anticoagulation Working Group.

Ann Pharmacother. 2005 Dec;39(12):1996-2002. Epub 2005 Nov 15.PMID: 16288081 [PubMed - indexed for MEDLINE]Related articles

Warfarin monitoring in patients with anticardiolipin antibodies, but without lupus anticoagulants.

Mant MJ, Stang L, Etches WS.

Thromb Res. 2000 Sep 1;99(5):477-82.PMID: 10973677 [PubMed - indexed for MEDLINE]Related articles

A clinical study monitoring low-intensity anticoagulant therapy with a standard-sensitivity thromboplastin.

Brophy MT, Fiore LD, Lau J, Headley E, Allen M, Deykin D.

Arch Pathol Lab Med. 1993 Jun;117(6):618-21.PMID: 8503734 [PubMed - indexed for MEDLINE]Related articles

Standardizing the prothrombin time. Calibrating coagulation instruments as well as thromboplastin.

Becker DM, Humphries JE, Walker FB 4th, DeMong LK, Bopp JS, Acker MN.

Arch Pathol Lab Med. 1993 Jun;117(6):602-5.PMID: 8503731 [PubMed - indexed for MEDLINE]Related articles

Warfarin monitoring by an anticoagulant therapy factor (ATF).

Carroll WE, Jackson RD, Carroll TA.

Res Commun Mol Pathol Pharmacol. 1998 Aug;101(2):159-70.PMID: 9821212 [PubMed - indexed for MEDLINE]Related articles

Comparison of native prothrombin antigen with the prothrombin time for monitoring oral anticoagulant prophylaxis.

Kornberg A, Francis CW, Pellegrini VD Jr, Gabriel KR, Marder VJ.

Circulation. 1993 Aug;88(2):454-60.PMID: 8339409 [PubMed - indexed for MEDLINE]Related articles